XML 44 R32.htm IDEA: XBRL DOCUMENT v3.20.2

Business Segment Information Business Segment Information (Tables)

6 Months Ended

Sep. 30, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Financial information for each of our segments is presented in the following table:

						Three Months Ended September 30,												Six Months Ended September 30,
						2020						2019						2020						2019
Revenues:
Healthcare						$	470,927					$	485,283					$	870,585					$	931,015
Applied Sterilization Technologies						169,547						152,907						321,909						307,193
Life Sciences						115,658						98,650						232,570						195,435
Total revenues						$	756,132					$	736,840					$	1,425,064					$	1,433,643
Operating income (loss):
Healthcare						$	104,796					$	103,035					$	187,153					$	193,550
Applied Sterilization Technologies						76,835						65,386						140,790						133,421
Life Sciences						46,433						32,315						94,894						65,354
Corporate						(58,155)						(50,956)						(110,522)						(106,353)
Total operating income before adjustments						$	169,909					$	149,780					$	312,315					$	285,972
Less: Adjustments
Amortization of acquired intangible assets (1)						$	21,955					$	18,952					$	39,455					$	35,901
Acquisition and integration related charges (2)						1,135						1,947						2,421						3,864
Redomiciliation and tax restructuring costs (3)						384						1,016						554						2,786
Net (gain) loss on divestiture of businesses (1)						(5)						50						5						2,476
Amortization of property "step up" to fair value (1)						714						446						1,317						1,181
COVID-19 incremental costs (4)						4,539						—						13,209						—
Restructuring charges (5)						(76)						636						90						2,943
Total operating income						$	141,263					$	126,733					$	255,264					$	236,821

Revenue from External Customers by Products and Services [Table Text Block]

						Three Months Ended September 30,												Six Months Ended September 30,
						2020						2019						2020						2019
Healthcare:
Capital equipment						$	131,673					$	152,631					$	259,755					273,486
Consumables						122,797						116,033						206,551						232,115
Service						216,457						216,619						404,279						425,414
Total Healthcare Revenues						$	470,927					$	485,283					$	870,585					$	931,015
Applied Sterilization Technologies Service Revenues						$	169,547					$	152,907					$	321,909					$	307,193
Life Sciences:
Capital equipment						$	29,241					$	26,462					$	59,671					$	53,231
Consumables						55,793						42,540						114,635						86,569
Service						30,624						29,648						58,264						55,635
Total Life Sciences Revenues						$	115,658					$	98,650					$	232,570					$	195,435
Total Revenues						$	756,132					$	736,840					$	1,425,064					$	1,433,643

Revenue from External Customers by Geographic Areas [Table Text Block]

			Three Months Ended September 30,												Six Months Ended September 30,
			2020						2019						2020						2019
Revenues:
Ireland			$	17,090					$	15,171					$	31,463					$	30,279
United States			549,449						538,101						1,041,157						1,049,253
Other locations			189,593						183,568						352,444						354,111
Total Revenues			$	756,132					$	736,840					$	1,425,064					$	1,433,643

Reconciliation of Assets from Segment to Consolidated

Assets include the current and long-lived assets directly attributable to the segment based on the management of the location or on utilization. Certain corporate assets were allocated to the reportable segments based on revenues. Assets attributed to sales and distribution locations are only allocated to the Healthcare and Life Sciences segments.

Individual facilities, equipment, and intellectual properties are utilized for production by both the Healthcare and Life Sciences segments at varying levels over time. As a result, an allocation of total assets, capital expenditures, and depreciation and amortization is not meaningful to the individual performance of the Healthcare and Life Sciences segments. Therefore, their respective amounts are reported together.

						September 30, 2020						March 31, 2020
Assets:
Healthcare and Life Sciences						$	2,642,515					$	2,705,377
Applied Sterilization Technologies						2,850,052						2,720,205
Total assets						$	5,492,567					$	5,425,582

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph a
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration